Congressional Drug and Terrorism Expert Says Legalization Could Cut Crime 5/10/02

Drug War Chronicle, recent top items


recent blog posts "In the Trenches" activist feed


As an international terrorism and narcotics specialist with the Congressional Research Service (CRS), Raphael Perl knows a thing or two about drug policy. While the reports CRS produces on numerous topics are generally objective and non-partisan -- therefore arguably of little use to most Congresspersons -- Perl is widely acknowledged to be a thoughtful analyst of drug and terrorism trends. He most recently polished his drug war bona fides by appearing at last December's DEA horse-and-pony show attempting to link drugs and terror, where he argued that terrorist organizations could not survive financially without the drug trade.

But Perl popped up last week in Jamaica singing a slightly different tune. Addressing the American Chamber of Commerce of Jamaica as the honored guest at its "Business Roundtable Breakfast" in Kingston on April 30, Perl told his audience that decriminalizing or legalizing drugs could lower crime rates, but at the cost of increased drug use.

"It is very clear that there is a direct correlation between decriminalization and legalization, and levels of addiction and drug use in a society," Perl said, as reported by the Jamaica Gleaner. "For the societies that have experimented in this area, drug use goes up... but crime goes down."

(The correlation may not be as crystal clear as Perl suggested, but the point is well-taken. Peter Reuter and Robert MacCoun's recent survey of the literature on drug policy in "Drug War Heresies: Learning from Other Vices, Times, and Places," found, for instance, increases in Dutch cannabis consumption came not after de facto decriminalization in 1976, but only later, with the commercialization and glamorization of cannabis in Holland. Increases in Italian heroin use correlated only erratically with changes in the drug's legal status. Increases in alcohol consumption in the US after Prohibition were delayed and, again, probably due to commercialization.)

But betraying a bias that runs deep in American discussions of drug policy -- that the only indicator that matters is drug use levels, not crime levels, not harm levels, not average consumption levels, only how many people are using drugs -- Perl shied away from endorsing decrim or legalization. "Do we want to make a trade-off in our society, where we have more drug use and less crime?" Perl asked the assembled businessmen and women. "I don't like legalization," Perl said, "but I think that this is a decision that each society has to make for itself."

Perl might want to tell that to the State Department, which has threatened Jamaica with dire consequences if a parliamentary move to decriminalize marijuana meets with success (

Perl told his audience that using drugs is something that "scares me" and constructed a nightmare scenario for the no doubt horrified entrepreneurs. "The possibility exists down the road, that we might have a synthetic drug that I slip into your drink and you are my slave for life," he said.

Exercises in speculative fantasy aside, Perl's remarks indicate that serious drug analysts, even those whose job it is to frighten congresspersons, understand the trade-off between prohibition and crime and are willing to mention the unmentionable: that societies may decide that a certain level of drug use is tolerable if it results in less social harm than drug prohibition. Now, if Perl would only repeat his remarks a little closer to home, like, say, Capitol Hill.

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #236, 5/10/02 Editorial: Unsafe Streets | Leading Education, Civil Rights, and Drug Policy Organizations Urge Congress to Repeal HEA Drug Provision in Full | Congressional Drug and Terrorism Expert Says Legalization Could Cut Crime | Needle Exchange Not Playing Well in Peoria | Philadelphia Trying to Quash Open-Air Drug Markets With Massive Police Presence | In Hartford, Neighborhood Drug Fighters and Drug Reformers Inhabit Parallel Universes | Million Marijuana March Hits 200 Cities Worldwide, Major Arrests Only in NYC | Patient's Hunger Strike for Medical Cannabis Enters Fourth Week | Newsbrief: FDA Okays Marijuana Hair Test, Would Detect Up to Three Months | Newsbrief: German Heroin Deaths Decline After Safe Injection Sites Introduced | Newsbrief: South Dakota Hemp Petition Signatures Submitted, Seeds Planted | Newsbrief: Philippine Official Asks End to Vigilante Killings of Drug Dealers, Users | Newsbrief: Canadian Senate Panel Hints at Marijuana Legalization | NPR and Reuters on HEA and SSDP | The Reformer's Calendar

This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]